Zortress

NDC 0078-0417 · Novartis Pharmaceuticals Corporation

Generic nameeverolimus

Dosage formTABLET

RouteORAL

Active ingredient(s)EVEROLIMUS

Strength.25 mg/1

Pharmacologic classCytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA]

Marketing categoryNDA

Packages

0078-0417-20 — 60 BLISTER PACK in 1 BOX (0078-0417-20) / 1 TABLET in 1 BLISTER PACK (0078-0417-61)

Billed under HCPCS

J7527 — Everolimus, oral, 0.25 mg Medicare Part B payment limit (ASP + 6%): $1.16

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0054-0470 — Everolimus, 0054-0471 — Everolimus, 0054-0472 — Everolimus, 0054-0480 — Everolimus, 0054-0481 — Everolimus, 0054-0482 — Everolimus, 0054-0497 — Everolimus, 0054-0604 — Everolimus, 0078-0414 — everolimus, 0078-0415 — everolimus, 0078-0422 — everolimus, 0078-0566 — everolimus, 0078-0567 — everolimus, 0078-0594 — everolimus, 0078-0620 — everolimus, 0078-0626 — everolimus, 0078-0627 — everolimus, 0078-0628 — everolimus, 0093-7766 — Everolimus, 0093-7767 — Everolimus, +63 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.